|
FEATURING PRECONFERENCE SESSIONS
|
- Asia Pacific Code Update
- Asia Pacific Transparency, Disclosure and Aggregate Spend Issues
|
|
|
AND MINI SUMMITS
|
- Mini Summit I: China Legal/Compliance Update
- Mini Summit II Asia Pacific Consumer Health Products Legal/Compliance Update
- Mini Summit III: Asia Pacific Acquisition/Merger Due Diligence Best Practices
- Mini Summit IV: India Legal/Compliance Update
- Mini Summit V: Interaction of UK Bribery Act, FCPA and Asia Pacific National Anti Corruption Laws
- Mini Summit VI: Managing Third Party Relationships
- Mini Summit VII: Responding to Government Investigations/Raids
- Mini Summit VIII: Clinical Trials Compliance Issues
- Mini Summit IX: Asia Pacific Fair Market Value Issues
|
|
|
SPECIALS SESSIONS
|
- The Role of Compliance in the Pharmaceutical Enterprise
- What is the 'Right Thing'? The Cultural Translation of Compliance
- The Evolving Legal/Compliance Environment in Asia Pacific Region
- Company Compliance Programmes with Respect to Third Party Intermediaries
- Korean Legal and Compliance Environment
- Overview of Chinese Pharma/Device Legal/Compliance Environment
- Overview of the Indian Pharma/Device Legal/Compliance Environment
- Cambodian Anti-Corruption Legislation
- Vietnam Code and Enforcement Update
- Amendments to Article 164 of the PRC Criminal Law
- Korean Duel Punishment Law
- Medicines Australia
- MCI Code of Medical Ethics
- Asia Pacific Market Access Issues
- The Whistleblower Reward Scheme (Dodd-Frank Act)
- Emerging Asia Pacific Transparency and Disclosure Laws
- Impact of US Sunshine Act on Pharma/Device Operations in Asia
|
|
|
FEATURED FACULTY
|
Ted Acosta, Esq.
Principal, Ernst & Young LLP, Former Senior Counsel, Office of Inspector General, US Department of Health and Human Services, New York, NY, USA and Paris, France |
Dr. Milind Antani
Head, Pharma, Life Science and Healthcare Practice, Nishith Desai Associates, Legal & Tax Counseling Worldwide, Mumbai, India |
John Auerbach, MA
Partner, Fraud Investigation & Dispute Services, Ernst & Young, Shanghai, China
|
John T. Bentivoglio, Esq.
Partner, Skadden Arps LLP, Former Special Counsel for Healthcare Fraud, and Chief Privacy Officer, US Department of Justice Washington, DC, USA |
Bridget Bourgeois
Partner, Ernst & Young, New York, NY, USA |
Maija Burtmanis, LLB, LLM
Regional Counsel, Japan/Asia Pacific, Novartis Vaccines, Former Regional Counsel, Pfizer Asia, Singapore
|
William E. Buzzeo, MS
Vice President and General Manager, Global Compliance Solutions, Cegedim Relationship Management, Richmond, VA, USA |
Li Cai, Esq.
Regional R&D Counsel, Asia Pacific, Pfizer Inc., Shanghai, China |
John Cannings
Partner, PricewaterhouseCoopers, Sydney, Australia
|
Eugene Chen, Esq.
Counsel, Hogan Lovells International LLP, Shanghai, China |
Hui Chen, Esq.
Senior Corporate Counsel, Asia-Pacific Regional Lead, International Compliance Investigations, Pfizer, New York, NY, USA |
Kyle Choi, Esq.
Health Law Group, Kim & Chang, Seoul, South Korea
|
Hwa-Soo Chung, Esq.
Chair, Health Law Group, Kim & Chang Law Firm, Seoul, South Korea |
Seck Yee Chung, Esq.
Partner and Chair, Vietnam Mergers & Acquisitions Practice, Baker & McKenzie (Vietnam) Ltd., Ho Chi Minh City, Vietnam |
Emma Davies, Esq.
Partner, Clifford Chance LLP, Singapore
|
Irina Dragulev, Esq.
Senior Corporate Counsel, Pfizer, New York, NY, USA |
Kimberly K. Egan, Esq.
Partner and Co-Chair, Health Care Sector, DLA Piper LLP, Washington, DC |
Kevin Foo
Area Compliance Officer - Asia Pacific, GlaxoSmithKline, Singapore
|
Balaji Ganesan
Partner, PricewaterhouseCoopers LLP, Singapore |
Qiao Gangliang, Esq.
Senior Vice President, Siemens Ltd., China, General Counsel & Compliance Officer North East Asia, Beijing, China |
Ronald Goon
Senior Director, Business Practices & Compliance, Office of Health Care Compliance & Privacy, Johnson & Johnson, Singapore
|
Edward Bramley Harker
Co-Leader, Global Pharmaceutical FMV Practice, PricewaterhouseCoopers LLP, London, UK |
Anwar Hashmi
Senior Manager - Ethics, Tata Steel, Ltd., Jamshedpur, India |
Thomas Kelly
Senior Vice President, Asia, sanofi-aventis, Shanghai, China
|
Homi R. Khusrokhan, FCA, M.Sc. (Econ.) London
Special Advisor, Govt.-appointed Board of Satyam Computer Services Ltd., Mumbai, India |
Keith M. Korenchuk, JD, MPH
Partner, Arnold & Porter LLP, Washington, DC, USA |
Steven J. Kuzma, CPA, MBA
Partner and Global Leader, Corporate Compliance Advisory Services, Ernst & Young, Atlanta, GA, USA
|
Carolyn Fitzhugh McNiven, Esq.
Partner, DLA Piper LLP, Former Assistant United States Attorney, US Attorney's Office, Northern District of Illinois, San Francisco, CA |
James R. Meehan
Partner, Advisory Forensic Services, PricewaterhouseCoopers LLP, San Francisco, CA, USA |
Kathleen Meriwether, Esq.
Principal, Ernst & Young, Former Assistant United States Attorney, US Attorney's Office for the Eastern District of Pennsylvania, Philadelphia, PA, USA
|
Chong Jin Ng, Esq.
Assistant General Counsel, Asia Pacific, GlaxoSmithKline, Singapore |
Vidya Rajarao
Executive Director and Leader, Forensic Services, PricewaterhouseCoopers LLP, Mumbai, India |
Lori Reber, Esq.
Vice President, Office of Ethics & Compliance, International and Emerging Markets, Smith & Nephew, Zürich, Switzerland
|
Brian Riewerts
Partner, Global Pharmaceuticals and Life Sciences, PricewaterhouseCoopers LLP, Baltimore, MD, USA |
Steven Robinson
Partner, Hogan Lovells International LLP, Beijing, China |
Bretton G. Sciaroni, Esq.
Partner, Sciaroni and Associates, Advisor to Royal Government of Cambodia, Phnom Penh, Cambodia
|
Sue Seferian, Esq.
Global R&D & Business Strategies Compliance Officer, Johnson & Johnson, New Brunswick, NJ, USA |
Arpinder Singh
Partner and National Director, Ernst & Young, Mumbai, India |
Dhinagar Subramanian, MD, MBA
Head, Regional Market Access Asia-Pacific, Bayer (South East Asia) Pte Ltd, Singapore
|
Sabina Sudan
Vice President, Compliance Officer - Emerging Markets Asia Pacific (EMAP) & Japan, GlaxoSmithKline Pte Ltd., Singapore |
Trudy Tan
Regional Compliance Director, AstraZeneca, Singapore |
Nicola Teo, Esq.
Senior Director - Legal, Business Development and RA/QA, St. Jude Medical, Hong Kong, China
|
Geeta Thakerar, Esq.
Regional Counsel, GlaxoSmithKline, Singapore |
Yuet-Ming Tham, Esq.
Partner and Head, Regulatory, Compliance, & Investigations Group, Asia, DLA Piper LLP, Hong Kong |
Lim Kai Toh, MD
Medical Affairs Manager, Pfizer, Singapore
|
Paul Vibert, MBA
Senior Vice President, Asia Pacific, Ferring Pharmaceuticals, Shanghai, China |
Vincent M. Walden, CFE, CPA, CITP
Senior Manager, Fraud Investigation & Dispute Services, Ernst & Young, Dallas, TX, USA |
Sow Wei Wong
Senior Compliance Counsel, Asia Pacific, Allergan, Inc.
|
Wendy L. Wysong, Esq.
Partner, Clifford Chance LLP, Hong Kong |
Kevin Yamaga-Karns, Esq.
Senior Director of Legal Affairs & Compliance, Eli Lilly Japan KK, Kobe, Japan |
Chen Yang, LLB, LLM
Partner, Global Life Sciences Team, Sidley Austin LLP, Beijing, China |
Ing Loong Yang, Esq.
Partner, Global Life Sciences Team, Sidley Austin LLP, Singapore |
Jessie Yap, Esq.
Chief Compliance Counsel, Asia Pacific/General Counsel, Australia & New Zealand, Covidien, Lane Cove, Australia |
Tom M. Zerull, CPA
Senior Manager Ethics & Compliance, International Operations, Abbott, Singapore
|
|
|
|
PARTICIPATION OPTIONS
|
|
TRADITIONAL ONSITE ATTENDANCE
|
|
Simply register, travel to the conference city and attend in person.
Pros: subject matter immersion; professional networking opportunities; faculty interaction
|
|
|
INTERNET INTERFACE SAMPLE
|
Click here for a sample stream
|
|
|
LIVE AND ARCHIVED INTERNET ATTENDANCE
|
|
Watch the conference in live streaming video over the Internet and at your convenience
at any time 24/7 for the six months following the event.
The archived conference includes speaker videos and coordinated PowerPoint presentations.
Pros: Live digital feed and 24/7 Internet access for next six months; Accessible in office, at home or anywhere worldwide with Internet access; Avoid travel expense and hassle; No time away from the office |
|
|
|
|
SAVE THE DATE
|
FOURTH ANNUAL SUMMIT ON DISCLOSURE, TRANSPARENCY AND AGGREGATE SPEND FOR DRUG, DEVICE AND BIOTECH COMPANIES
A Hybrid Conference and Internet Event
March 26 - 28, 2012
Renaissance Hotel
Washington, DC
www.DisclosureSummit.com
|
|
SIXTH INTERNATIONAL PHARMACEUTICAL REGULATORY AND COMPLIANCE CONGRESS
Sponsored by Pharmaceutical Compliance Forum
May 14 - 16, 2012
Budapest, Hungary
www.InternationalPharmaCongress.com
|
|
FIRST LATIN AMERICAN PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS
Sponsored by the Pharmaceutical Compliance Forum and the Latin American Ethics & Compliance Network
October, 2012
Sao Paulo, Brazil
www.LatinAmericanPharmaCongress.com
|
|
THIRTEENTH PHARMACEUTICAL REGULATORY AND COMPLIANCE CONGRESS
Sponsored by Pharmaceutical Compliance Forum
November 5 - 7, 2012
Grand Hyatt
Washington, DC
www.PharmaCongress.com
|
|
|
|
|
|
SPONSORED BY:
|
|
The Pharmaceutical Compliance Forum (PCF) is a coalition of senior compliance professionals and legal counsel from more than 50 of the largest research-based pharmaceutical manufacturers. The PCF was founded in early-1999 by compliance professionals from the pharmaceutical industry to promote effective corporate compliance programs.
|
|
The Asia Pacific Healthcare Industry Compliance Team is an ad hoc, voluntary group of Asia Pacific pharmaceutical, medical device and other life sciences company compliance professionals and legal counsel who meet quarterly to discuss legal and compliance issues and best practices.
|
|
|
|
|
CO CHAIRS
|
Manuel Flores
Compliance Director Asia Pacific, Bayer (South East Asia) Pte Ltd, Singapore
|
Kelly B. Freeman, PhD
Ethics and Compliance Officer, Eli Lilly and Company, Executive Committee Member, Pharmaceutical Compliance Forum, Indianapolis, IN, USA
|
Abdul Luheshi, MBA, PhD
Vice President Health Care Compliance, Asia Pacific, Johnson & Johnson, Singapore
|
Maria "Maru" Quindimil, MBA
AP & China Regional Compliance Officer, Merck Sharp and Dohme (Asia Ltd.), Manila, Philippines
|
|
GRANTORS:
|
|
DIAMOND
|
|
|
GOLD
|
|
|
SILVER
|
|
|
BRONZE
|
|
|
MEDIA PARTNER
|
|
|
OTHER MEDIA PARTNERS
|
|
|
ASIA PACIFIC PHARMA CONGRESS PLANNING COMMITTEE
|
Co chairs:
Manuel Flores
Compliance Director Asia Pacific, Bayer (South East Asia) Pte Ltd, Singapore
Kelly B. Freeman, PhD
Ethics and Compliance Officer, Eli Lilly and Company, Executive Committee Member, Pharmaceutical Compliance Forum, Indianapolis, IN, USA
Abdul Luheshi, MBA, PhD
Vice President Health Care Compliance, Asia Pacific, Johnson & Johnson, Singapore
Maria "Maru" Quindimil, MBA
AP & China Regional Compliance Officer, Merck Sharp and Dohme (Asia Ltd.), Manila, Philippines
Committee:
Ted Acosta, Esq.
Principal, Ernst & Young LLP, New York, NY, USA and Paris, France
Rebecca Allsopp, Esq.
Legal Counsel, sanofi-aventis, Sydney, Australia
Wayne Baker
Sr. Vice President, Advanced Health Media LLC, Bridgewater, NJ, USA
Scott Bass, Esq.
Partner and Chair, Global Life Sciences Team, Sidley Austin LLP, Washington, DC, USA
John T. Bentivoglio, Esq.
Partner, Skadden Arps LLP, Washington, DC, USA
Hui Chen, Esq.
Senior Corporate Counsel, Asia-Pacific Regional Lead, International Compliance Investigations, Pfizer, New York, NY, USA
Qiao Gangliang, Esq.
Senior Vice President, Siemens Ltd., China, General Counsel & Compliance Officer North East Asia, Beijing, China
Gareth Lee, Esq.
Associate General Counsel, Asia Pacific, Allergan Inc., Singapore
Liz MacGillivray
Head of Compliance AMAC Region (Asia Pacific, Middle East & African Countries), Novartis, Jumeirah Village, United Arab Emirates
Toon-Lee Ng, MBA
Regional Head of Quality Systems and Compliance, Japan - Asia Pacific, Genzyme, Singapore
Brian Riewerts
Partner, Global Pharmaceuticals and Life Sciences, PricewaterhouseCoopers LLP, Baltimore, MD, USA
Guillaume Roussel
Vice President, Compliance Solutions EMEA, Cegedim Relationship Management, Paris, France
Sabina Sudan
Vice President, Compliance Officer - Emerging Markets Asia Pacific (EMAP) & Japan, GlaxoSmithKline Pte Ltd., Singapore
Trudy Tan
Regional Compliance Director, AstraZeneca, Singapore
Yuet-Ming Tham, Esq.
Partner and Head, Regulatory, Compliance & Investigations Group, Asia, DLA Piper LLP, Hong Kong
Jun Wei, Esq.
Managing Partner, Beijing Office, Hogan Lovells International LLP, Beijing and Shanghai, China
Tom M. Zerull
Senior Manager Ethics & Compliance, International Operations, Abbott, Singapore
|
|
|
OTHER INTERNATIONAL PHARMA CONGRESSES
|
2007 - Brussels, Belgium
2008 - Paris, France
2009 - Rome, Italy
2010 - Berlin, Germany
2011 - Istanbul, Turkey
|
|
|
FOLLOW ASIA PACIFIC PHARMA CONGRESS ON
|
|
|
|
|
|
|
